Alvotech (ALVO) Receivables (2020 - 2026)
Alvotech's (ALVO) quarterly Receivables came in at $211.6 million in Q2 2026, up 50.95% on a YoY basis from $140.2 million in Q2 2025, and up 18.97% quarter-over-quarter from $177.9 million in Q1 2026.
Analysis
Alvotech (ALVO) Receivables (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Receivables for 7 consecutive years, with $211.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables rose 50.95% year-over-year to $211.6 million; the trailing twelve-month figure through Jun 2026 stood at $211.6 million (up 50.95% YoY), and the FY2025 full-year result was $192.7 million, up 5.33% from the prior year.
- Receivables improved to $211.6 million in Q2 2026 per ALVO's latest filing, from $177.9 million in the prior quarter.
- Across five years, Receivables topped out at $218.9 million in Q3 2025 and bottomed at $20.1 million in Q2 2022.
- Historically, Receivables has averaged $123.8 million across 5 years, with a median of $133.6 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Receivables soared 415.77% in 2024, then declined 6.9% in 2026.
- Over 5 years, Receivables stood at $36.3 million in 2022, then surged by 43.82% to $52.1 million in 2023, then surged by 250.78% to $182.9 million in 2024, then climbed by 5.33% to $192.7 million in 2025, then rose by 9.82% to $211.6 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $211.6 million, $177.9 million, and $192.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 3.49 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 3.67 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 1.06 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 1.61 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 2.26 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 274.47 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 211.59 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 145.76 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 23.27 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | 123,592.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 211.59 Mn |
| Mar 31, 2026 | 177.85 Mn |
| Dec 31, 2025 | 192.67 Mn |
| Sep 30, 2025 | 218.91 Mn |
| Jun 30, 2025 | 140.17 Mn |
| Mar 31, 2025 | 191.03 Mn |
| Dec 31, 2024 | 182.93 Mn |
| Sep 30, 2024 | 106.25 Mn |
| Jun 30, 2024 | 126.98 Mn |
| Mar 31, 2024 | 51.61 Mn |
| Dec 31, 2023 | 52.15 Mn |
| Jun 30, 2023 | 24.62 Mn |
| Dec 31, 2022 | 36.26 Mn |
| Jun 30, 2022 | 20.14 Mn |
| Dec 31, 2021 | 30.88 Mn |
| Dec 31, 2020 | 2.77 Mn |